Critic at Large

» funding, science publishing, opinion and cancer

Most Recent

image: Opinion: Understanding and Coping With Rising Publication Costs

Opinion: Understanding and Coping With Rising Publication Costs

By M. Bishr Omary and Theodore S. Lawrence | September 1, 2017

As article processing charges top $5,000 at some research journals, authors and institutions have means of negotiating better deals or finding less expensive options.

0 Comments

image: Opinion: Why I Published in a Predatory Journal

Opinion: Why I Published in a Predatory Journal

By John H. McCool | April 6, 2017

Our totally bogus case report swiftly passed muster, with only minor revisions requested.

12 Comments

Measuring PD-L1 levels was a great start. Now we need to quantify more protein biomarkers, assess the tumor mutational landscape, and examine immune cell signatures, too.

0 Comments

image: Pet Scans

Pet Scans

By Timothy M. Fan, Amy K. LeBlanc, and Nicola Mason | April 1, 2016

Studying tumor development and treatment in dogs and cats, in parallel with research on rodents and humans, could improve the successful translation of new cancer drugs.

0 Comments

image: Control ALT, Delete Cancer

Control ALT, Delete Cancer

By Haroldo Silva, David Halvorsen, and Jeremy D. Henson | April 1, 2015

Treating cancer by shutting down the alternative lengthening of telomeres (ALT) pathway

1 Comment

image: The Challenges of Precision

The Challenges of Precision

By Adam Marcus | April 1, 2015

Researchers face roadblocks to treating an individual patient’s cancer as a unique disease.

1 Comment

image: Fighting Cancer with Nanomedicine

Fighting Cancer with Nanomedicine

By Dean Ho | April 1, 2014

Nanotechnology-based therapeutics will revolutionize cancer treatment.

2 Comments

image: Defending Against Plagiarism

Defending Against Plagiarism

By Jonathan Bailey | June 1, 2013

Publishers need to be proactive about detecting and deterring copied text.

5 Comments

image: Researchers, Hire Hackers

Researchers, Hire Hackers

By Zeke Nierenberg and Martina Steurer-Muller | May 1, 2013

Clinical researchers need programming support to streamline their work, minimize error in the data, and find new trends that can point to better treatments.

0 Comments

image: Cancer Clinical Trials of Tomorrow

Cancer Clinical Trials of Tomorrow

By Tomasz M. Beer | April 1, 2013

Advances in genomics and cancer biology will alter the design of human cancer studies.

0 Comments

Popular Now

  1. DNA Robots Target Cancer
    Daily News DNA Robots Target Cancer

    Researchers use DNA origami to generate tiny mechanical devices that deliver a drug that cuts off the blood supply to tumors in mice.

  2. Love in the Scientific Literature
    News Analysis Love in the Scientific Literature

    There are countless ways for scientists to say, “I love you.” Naming a slime-mold beetle after your wife (and another after your ex-wife) is, apparently, one of them.  

  3. Stem Cell Vaccine Protects Mice From Cancer
  4. Gene Expression Overlaps Among Psychiatric Disorders
AAAS